Bengaluru-based health diagnostic company Acculi Labs announced that it had raised Rs 5 crore (about $700,000) in a seed funding round from PirE Ventures, an investment firm based out of Mumbai. Started in May 2017, by Rupam Das, Acculi Labs aims to make home-based care available to the last person at the bottom of the pyramid. It’s flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients even in the remotest part of the world and helps them to approach their doctor at an early stage.